Adaptive Biotechnologies Corporation (ADPT)
Market Closed
3 Jun, 20:00
$
15. 99
+0.85
+5.6143%
$
2.42B Market Cap
- P/E Ratio
- Div Yield
2.24M Volume
-1.38 Eps
$ 15.14
Previous Close Want to track ADPT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Adaptive Biotechnologies (ADPT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Adaptive Biotechnologies (ADPT) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks | 1 year ago
Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates
Adaptive Biotechnologies (ADPT) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.33 per share a year ago.
Zacks | 1 year ago
3 Precision Medicine Stocks Tailoring Treatments
Two elements favor the case for acquiring precision medicine stocks. First, the obvious point: barring extraordinary circumstances, the broader healthcare ecosystem will always be relevant.
Investorplace | 1 year ago
Mighty Mites: 3 Small-Cap Stocks Packing a Powerful Punch
To be completely upfront, small-cap stocks to buy are risky. They're the equivalent of plus-money bets or plus odds.
Investorplace | 2 years ago
